Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugs.

MLA

Adams, Joëlla W., et al. “Receipt of Opioid Agonist Treatment Halves the Risk of HIV-1 RNA Viral Load Rebound through Improved ART Adherence for HIV-Infected Women Who Use Illicit Drugs.” Drug and Alcohol Dependence, vol. 206, Jan. 2020, p. 107670. EBSCOhost, https://doi.org/10.1016/j.drugalcdep.2019.107670.

APA

Adams, J. W., Marshall, B. D. L., Mohd Salleh, N. A., Barrios, R., Nolan, S., & Milloy, M.-J. (2020). Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugs. Drug and Alcohol Dependence, 206, 107670. https://doi.org/10.1016/j.drugalcdep.2019.107670

Chicago

Adams, Joëlla W, Brandon D L Marshall, Nur Afiqah Mohd Salleh, Rolando Barrios, Seonaid Nolan, and M-J Milloy. 2020. “Receipt of Opioid Agonist Treatment Halves the Risk of HIV-1 RNA Viral Load Rebound through Improved ART Adherence for HIV-Infected Women Who Use Illicit Drugs.” Drug and Alcohol Dependence 206 (January): 107670. doi:10.1016/j.drugalcdep.2019.107670.